Latest Posts › CRISPR

Share:

CRISPR Patent Watch

The U.S. Patent and Trademark Office today granted U.S. Patent 10,227,611 to Jennifer Doudna, Martin Jinek, Krzysztof Chylinski, and Emmanuelle Charpentier, the patent entitled "Methods and compositions for RNA-directed...more

3/13/2019  /  CRISPR , DNA , Life Sciences , Patents , USPTO

Whither CRISPR? University of California/Berkeley Granted Another CRISPR Patent

The U.S. Patent and Trademark Office granted U.S. Patent No. 10,113,167 today, October 30, 2018, to the University of California/Berkeley, directed to an aspect of its CRISPR technology (where CRISPR is an acronym for...more

Enhanced Mutagenesis Methods

Ulrich (Uli) Laemmli, an illustrious professor of biochemistry and molecular biology, developer of SDS (sodium dodecyl sulfate)-polyacrylamide electrophoresis (PAGE) for separating proteins, and responsible for identifying...more

10/3/2018  /  CRISPR , DNA , Life Sciences

Regents of the University of California v. Broad Institute, Inc. (Fed. Cir. 2018)

Federal Circuit Affirms PTAB in Appeal of CRISPR Interference - Barring the unlikely event that the Federal Circuit rehears en banc today's decision in Regents of the University of California v. Broad Institute, Inc. (or,...more

Federal Circuit Affirms PTAB Decision in CRISPR Case

On Monday, September 10, 2018, the Federal Circuit handed down its decision in the University of California’s (“California”) appeal of the decision by the Patent Trial and Appeal Board (“the Board”) that there is no...more

The CRISPR Chronicles -- Broad Institute Wins One and Loses One

The interference between the Broad Institute and the University of California/Berkeley has been in the spotlight over the past year. But there have been other skirmishes between the parties, each of which has recently been...more

Berkeley Files Opening Brief in CRISPR Appeal

The University of California/Berkeley filed its opening brief to the Federal Circuit last week, asking that Court to overturn the Patent Trial and Appeal Board's decision that there was no interference-in-fact between...more

University of California/Berkeley Appeals Adverse CRISPR Decision by PTAB

In February, the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office rendered judgment that there was no interference-in-fact between the claims in interference between the Regents of the University...more

PTAB Decides CRISPR Interference in Favor of Broad Institute -- Their Reasoning

On February 15, 2017, the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office rendered judgment that there was no interference-in-fact between the claims in interference between the Regents of the...more

159 Results
 / 
View per page
Page: of 7

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide